The efficacy and safety of molidustat for anemia in dialysis-dependent and non-dialysis-dependent chronic kidney disease patients: A systematic review and meta-analysis.

Heliyon · 2024 · PMC11101811 · PMID 38765138

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

In this study, one trial reported that for DD patients there was an increasing trend of serum VEGF in the molidustat group when compared to ESA group, while the clinical impact remained unclear in this trial [ 22 ].

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.